
Please try another search
Symbol | Exchange | Currency | ||
---|---|---|---|---|
SGIOY | OTC Markets | USD | Delayed | |
4507 | Frankfurt | EUR | Delayed | |
4507 | Tokyo | JPY | Delayed |
Shionogi & Co., Ltd. researches, develops, manufactures, and distributes pharmaceuticals, diagnostic reagents, and medical devices. It offers and develops drugs in the areas of infectious diseases, COVID-19, tumors, sclerosis, pomp, fragile X syndrome, and other diseases. The company was formerly known as Shionogi Shoten Co., Ltd. and changed its name to Shionogi & Co., Ltd. in 1943. Shionogi & Co., Ltd. was founded in 1878 and is headquartered in Osaka, Japan.
Name | Age | Since | Title |
---|---|---|---|
Isao Teshirogi | 66 | 2002 | CEO, President & Representative Director |
Keiichi Ando | 74 | 2016 | Independent Chairperson of the Board |
Shuichi Okuhara | 57 | 2020 | Independent Outside Director |
Koji Hanasaki | 64 | 2017 | Director |
John A. Keller | 61 | 2017 | Senior Exec. Officer, SVP of R&D Supervisory Unit and Pharma. Tech. Research Div. & Director |
Fumi Takatsuki | 50 | 2020 | Independent Outside Director |
Takaoki Fujiwara | 73 | 2018 | Independent Outside Director |
Hiroshi Ozaki | 75 | 2019 | Independent Outside Director |
Noriyuki Kishida | 65 | 2022 | Independent Outside Director |
Yoriko Goto | 67 | 2023 | Independent Outside Director |
Kyoko Hirose | 66 | 2025 | Independent Outside Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review